987 related articles for article (PubMed ID: 17055063)
41. Zopiclone misuse: an update from Dublin.
Bannan N; Rooney S; O'connor J
Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
[TBL] [Abstract][Full Text] [Related]
42. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
43. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
Kerr T; Marsh D; Li K; Montaner J; Wood E
Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
[TBL] [Abstract][Full Text] [Related]
44. Psychiatric comorbidity of patients on methadone maintenance treatment with a history of sexual abuse.
Peles E; Potik D; Schreiber S; Bloch M; Adelson M
Eur Neuropsychopharmacol; 2012 Dec; 22(12):883-91. PubMed ID: 22564825
[TBL] [Abstract][Full Text] [Related]
45. [The impact of substitution treatment by methadone among opiate-dependent subjects evaluated by Addiction Severity Index and by urine tests].
Trémeau F; Darreye A; Khidichian F; Weibel H; Kempf M; Greth P; Schneider JL; Wantz C; Weber B; Stépien S; Macher JP
Encephale; 2002; 28(5 Pt 1):448-53. PubMed ID: 12386547
[TBL] [Abstract][Full Text] [Related]
46. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
Camacho A; Akiskal HS
J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
[TBL] [Abstract][Full Text] [Related]
47. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
48. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
[TBL] [Abstract][Full Text] [Related]
49. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
Lavie E; Fatséas M; Denis C; Auriacombe M
Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
[TBL] [Abstract][Full Text] [Related]
50. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
Hiltunen AJ; Eklund C; Borg S
Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
[TBL] [Abstract][Full Text] [Related]
51. Pain depression and sleep disorders among methadone maintenance treatment patients.
Pud D; Zlotnick C; Lawental E
Addict Behav; 2012 Nov; 37(11):1205-10. PubMed ID: 22742985
[TBL] [Abstract][Full Text] [Related]
52. Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment.
Malik E; Adelson M; Sason A; Schreiber S; Peles E
J Dual Diagn; 2019; 15(4):281-290. PubMed ID: 31530109
[No Abstract] [Full Text] [Related]
53. Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors.
Sason A; Adelson M; Schreiber S; Peles E
Drug Alcohol Depend; 2018 Aug; 189():8-11. PubMed ID: 29857329
[TBL] [Abstract][Full Text] [Related]
54. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
[TBL] [Abstract][Full Text] [Related]
55. Substance abuse in hospitalized psychiatric patients.
Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
Isr Med Assoc J; 2008 Oct; 10(10):672-5. PubMed ID: 19009943
[TBL] [Abstract][Full Text] [Related]
56. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
Maremmani I; Pani PP; Mellini A; Pacini M; Marini G; Lovrecic M; Perugi G; Shinderman M
J Addict Dis; 2007; 26(1):61-70. PubMed ID: 17439869
[TBL] [Abstract][Full Text] [Related]
57. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
[TBL] [Abstract][Full Text] [Related]
58. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.
King VL; Kidorf MS; Stoller KB; Brooner RK
J Addict Dis; 2000; 19(4):65-83. PubMed ID: 11110066
[TBL] [Abstract][Full Text] [Related]
59. Psychotherapeutic benefits of opioid agonist therapy.
Tenore PL
J Addict Dis; 2008; 27(3):49-65. PubMed ID: 18956529
[TBL] [Abstract][Full Text] [Related]
60. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
